Quick Answer
Niagen Bioscience, Inc. reported Gross Profit of $83.19 million for the year ending 2025.
- Niagen Bioscience, Inc. showed an increase of +35.1% in Gross Profit from 2024 to 2025.
- This data is from Niagen Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: $764.7 thousand | Q3 2012: $1.25 million | Q1 2013: $672.8 thousand | Q2 2013: $960.7 thousand | Q3 2013: $750.2 thousand | Q4 2013: $749.4 thousand | Q1 2014: $985.0 thousand | Q2 2014: $1.40 million | Q3 2014: $1.52 million | Q4 2014: $1.42 million | Q1 2015: $1.93 million | Q2 2015: $2.47 million | Q3 2015: $2.48 million | Q4 2015: $1.60 million | Q1 2016: $2.84 million | Q2 2016: $3.67 million | Q3 2016: $1.86 million | Q4 2016: $2.01 million | Q1 2017: $1.62 million | Q2 2017: $2.11 million | Q3 2017: $2.92 million | Q4 2017: $3.83 million | Q1 2018: $3.14 million | Q2 2018: $3.85 million | Q3 2018: $4.36 million | Q1 2019: $5.30 million | Q2 2019: $6.25 million | Q3 2019: $6.75 million | Q1 2020: $8.31 million | Q2 2020: $9.09 million | Q3 2020: $8.45 million | Q1 2021: $9.23 million | Q2 2021: $10.81 million | Q3 2021: $10.58 million | Q1 2022: $10.53 million | Q2 2022: $10.04 million | Q3 2022: $10.21 million | Q1 2023: $13.52 million | Q2 2023: $12.36 million | Q3 2023: $11.97 million | Q1 2024: $13.46 million | Q2 2024: $13.69 million | Q3 2024: $16.24 million | Q1 2025: $19.33 million | Q2 2025: $20.23 million | Q3 2025: $21.93 million.
- Over the full 16 years of available data (2010 to 2025), Niagen Bioscience, Inc.'s Gross Profit has grown by 2,724.9%.
- Historical annual values: Fiscal year 2025: $83.19 million | Fiscal year 2024: $61.59 million | Fiscal year 2023: $50.78 million | Fiscal year 2022: $42.80 million | Fiscal year 2021: $41.49 million | Fiscal year 2020: $35.27 million | Fiscal year 2019: $25.77 million | Fiscal year 2018: $16.06 million | Fiscal year 2017: $10.48 million | Fiscal year 2016: $10.39 million | Fiscal year 2015: $7.53 million | Fiscal year 2014: $5.33 million | Fiscal year 2013: $3.13 million | Fiscal year 2012: $2.28 million | Fiscal year 2011: $2.47 million | Fiscal year 2010: $2.94 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: